<p>直覺外科（NASDAQ:ISRG - 獲取免費報告）在華爾街 Zen 的股票研究分析師的研究報告中，將其評級從 “持有” 上調至 “買入”。</p>
<p>獲取 <strong>Intuitive Surgical</strong> 的提醒：</p>
<ul>
<li>Intuitive Surgical 的拋售為 30% 的反彈機會鋪平了道路</li>
</ul>
<p>其他一些分析師最近也對 ISRG 發佈了報告。Evercore 將 Intuitive Surgical 的目標價從 550.00 美元下調至 480.00 美元，並在 4 月 6 日的研究報告中給予該公司 “中性” 評級。Barclays 在 4 月 23 日的研究報告中將 Intuitive Surgical 的目標價設定為 651.00 美元，並給予該公司 “增持” 評級。Robert W. Baird 在 4 月 22 日的報告中將 Intuitive Surgical 的目標價從 575.00 美元上調至 610.00 美元，並給予該公司 “跑贏大盤” 評級。Jefferies Financial Group 在 4 月 22 日的報告中將 Intuitive Surgical 的目標價從 560.00 美元下調至 515.00 美元，並對該股票給予 “持有” 評級。最後，BTIG Research 在 4 月 22 日的報告中重申了 “買入” 評級，並將 Intuitive Surgical 的目標價設定為 574.00 美元。共有 18 位股票研究分析師對該股票給予了買入評級，7 位給予了持有評級，1 位給予了賣出評級。根據 MarketBeat 的數據，該股票目前的平均評級為 “適度買入”，共識目標價為 581.91 美元。</p>
<p><strong>查看我們關於 Intuitive Surgical 的最新股票報告</strong></p>
<h2>Intuitive Surgical 股價下跌 1.6%</h2>
<ul>
<li>5 只股票在 AI 超級推動下快速上漲</li>
</ul>
<p>ISRG 週五開盤價為 421.12 美元。該股票的市值為 1491.4 億美元，市盈率為 51.04，PEG 比率為 3.42，貝塔係數為 1.51。Intuitive Surgical 的一年低點為 417.74 美元，一年高點為 603.88 美元。該股票的 50 日移動平均價格為 463.63 美元，200 日移動平均價格為 514.04 美元。</p>
<p>直覺外科（NASDAQ:ISRG - 獲取免費報告）最近於 4 月 21 日發佈了季度財報。該醫療設備提供商報告每股收益（EPS）為 2.50 美元，超出分析師共識預期的 2.08 美元，超出幅度為 0.42 美元。該公司在本季度的收入為 27.7 億美元，而分析師預期為 26.2 億美元。Intuitive Surgical 的股本回報率為 15.98%，淨利潤率為 28.15%。該公司的季度收入同比增長 23.0%。去年同期，該公司每股收益為 1.81 美元。作為一個整體，賣方分析師預測 Intuitive Surgical 在當前財政年度將發佈 8.57 美元的每股收益。</p>
<h2>Intuitive Surgical 的內部活動</h2>
<ul>
<li>超越生物技術——3 只適合成長型投資者的醫療股票</li>
</ul>
<p>在其他 Intuitive Surgical 的新聞中，執行副總裁 Gary Loeb 於 5 月 11 日星期一出售了 400 股該公司的股票。股票以平均價格 446.95 美元出售，總交易額為 178,780.00 美元。交易後，該執行副總裁直接持有該公司 6,120 股，價值 2,735,334 美元。此交易代表其持股比例減少了 6.13%。該交易已在證券交易委員會的備案中披露，相關信息可在 SEC 網站上查閲。該交易是在預先安排的 10b5-1 交易計劃下執行的。此外，資深副總裁 Mark Brosius 於 3 月 4 日星期三出售了 2,362 股該公司的股票。股票以平均價格 498.68 美元出售，總價值為 1,177,882.16 美元。交易後，資深副總裁持有該公司 3,554 股，價值約 1,772,308.72 美元。此交易代表其持股比例減少了 39.93%。有關此銷售的更多詳細信息可在官方 SEC 披露中找到。在過去一個季度中，內部人士出售了價值 2,760,359 美元的 5,647 股公司股票。內部人士持有該公司股票的 0.60%。</p>
<h2>對 Intuitive Surgical 的對沖基金看法</h2>
<p>一些機構投資者最近對該公司的持倉進行了調整。Gateway Wealth Partners LLC 在第一季度購買了 Intuitive Surgical 的新股份，價值約 409,000 美元。Blue Chip Partners LLC 在第一季度將其在 Intuitive Surgical 的股份增加了 6.0%。Blue Chip Partners LLC 目前持有該醫療設備提供商的 2,274 股股票，價值 1,048,000 美元，此前在該期間內又購買了 129 股。Weiss Asset Management LP 在第一季度購買了 Intuitive Surgical 的新股份，價值約 5,808,000 美元。OMERS ADMINISTRATION Corp 在第一季度將其在 Intuitive Surgical 的股份增加了 98.4%。OMERS ADMINISTRATION Corp 目前持有該醫療設備提供商的 289,024 股股票，價值 133,237,000 美元，此前在該期間內又購買了 143,345 股。最後，Bradley Foster &amp; Sargent Inc. CT 在第一季度將其在 Intuitive Surgical 的股份增加了 3.7%。Bradley Foster &amp; Sargent Inc. CT 目前持有該醫療設備提供商的 50,697 股股票，價值 23,371,000 美元，此前在該期間內又購買了 1,797 股。83.64% 的股票目前由機構投資者持有。</p>
<h2>影響 Intuitive Surgical 的關鍵故事</h2>
<p>以下是本週影響 Intuitive Surgical 的關鍵新聞故事：</p>
<ul>
<li>積極情緒：多篇近期文章強調了直覺外科（Intuitive Surgical）作為醫療保健領域人工智能浪潮的潛在受益者，認為每一次機器人手術都會產生有價值的數據，從而改善外科醫生培訓、術中指導和預測分析。手術機器人與人工智能的結合：直覺外科、美敦力（Medtronic）和史崔克（Stryker）是醫療保健繁榮的潛在黑馬。</li>
<li>積極情緒：Erste Group Bank 的分析師上調了對 ISRG 的 2026 財年和 2027 財年的盈利預期，強化了盈利增長能夠持續超過市場共識的預期。MarketBeat 對 ISRG 的覆蓋。</li>
<li>積極情緒：關於達芬奇 5（da Vinci 5）的報道指出手術增長強勁，系統利用率提高，表明該公司的最新平台仍在外科醫生和醫院中獲得認可。ISRG 的達芬奇 5 能否維持手術和利用率的增長？</li>
<li>中性情緒：幾篇樂觀的評論文章表示，近期的拋售使得直覺外科對成長型投資者更具吸引力，但這些主要是評論而非新的公司特定催化劑。直覺外科今年已下跌 20%。華爾街表示，現在是買入的時機。</li>
</ul>
<h2>直覺外科公司簡介</h2>
<p>(獲取免費報告)</p>
<p>直覺外科成立於 1995 年，總部位於加利福尼亞州陽光谷，是一家專注於設計、製造和服務機器人輔助手術系統的醫療技術公司。該公司以其達芬奇手術系統而聞名，該系統通過將外科醫生的手部動作轉化為患者體內小型儀器的更精細、縮放的運動，從而實現微創手術。直覺的業務集中在向醫院和手術中心提供系統、儀器及相關技術，旨在提高手術室的精確度、可視化和控制能力。</p>
<p>除了其核心手術平台外，直覺還銷售一系列可重複使用和一次性使用的儀器、配件和專有軟件，併為客户提供培訓、服務和臨牀支持。</p>
<h2>進一步閲讀</h2>
<ul>
<li>我們更看好的五隻股票，勝過直覺外科</li>
<li>維京航運（Viking）創下歷史新高——基本面信號顯示未來還有更多</li>
<li>數據庫（Datavalut）獲得關注：現在賣出的五個理由</li>
<li>TMC 股票：為什麼這家尚未盈利的礦業公司值得關注</li>
<li>電網正在衰退——是時候購買其替代品了嗎？</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SVNSRw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="650" height="330" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SVNSRw"/></p>
<p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。如對本故事有任何問題或意見，請發送郵件至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1,000 美元在直覺外科嗎？</h2>
<p>在考慮直覺外科之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其向客户推薦的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前買入……而直覺外科並不在名單上。</p>
<p>雖然直覺外科目前在分析師中獲得了中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

直覺外科

ISUL

美國醫藥設備 ETF - iShares

標普健康醫療設備 ETF - SPDR

<p>華爾街禪將直覺外科（NASDAQ:ISRG）的評級從 “持有” 上調至 “買入”。其他分析師的意見各不相同，Evercore 將其目標價下調至 480 美元，而巴克萊則將其目標價設定為 651 美元。該股票目前的平均評級為 “適度買入”，共識目標價為 581.91 美元。直覺外科報告每股收益為 2.50 美元，超出預期，收入同比增長 23%</p>

<p>Intuitive Surgical (NASDAQ:ISRG - Get Free Report) was upgraded by equities research analysts at Wall Street Zen from a &#34;hold&#34; rating to a &#34;buy&#34; rating in a research note issued to investors on Saturday.</p>
<div class="lb-trans"><p>直覺外科（NASDAQ:ISRG - 獲取免費報告）在華爾街 Zen 的股票研究分析師的研究報告中，將其評級從 “持有” 上調至 “買入”。</p>
</div><p>Get <strong>Intuitive Surgical</strong> alerts:</p>
<div class="lb-trans"><p>獲取 <strong>Intuitive Surgical</strong> 的提醒：</p>
</div><ul>
<li>Intuitive Surgical's Selloff Sets Up a 30% Rebound Opportunity</li>
</ul>
<div class="lb-trans"><ul>
<li>Intuitive Surgical 的拋售為 30% 的反彈機會鋪平了道路</li>
</ul>
</div><p>A number of other analysts have also recently issued reports on ISRG. Evercore reduced their price objective on Intuitive Surgical from $550.00 to $480.00 and set a &#34;neutral&#34; rating for the company in a research report on Monday, April 6th. Barclays set a $651.00 price objective on Intuitive Surgical and gave the company an &#34;overweight&#34; rating in a research report on Thursday, April 23rd. Robert W. Baird raised their target price on Intuitive Surgical from $575.00 to $610.00 and gave the company an &#34;outperform&#34; rating in a report on Wednesday, April 22nd. Jefferies Financial Group cut their target price on Intuitive Surgical from $560.00 to $515.00 and set a &#34;hold&#34; rating on the stock in a report on Wednesday, April 22nd. Finally, BTIG Research restated a &#34;buy&#34; rating and set a $574.00 target price on shares of Intuitive Surgical in a report on Wednesday, April 22nd. Eighteen equities research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the stock currently has an average rating of &#34;Moderate Buy&#34; and a consensus target price of $581.91.</p>
<div class="lb-trans"><p>其他一些分析師最近也對 ISRG 發佈了報告。Evercore 將 Intuitive Surgical 的目標價從 550.00 美元下調至 480.00 美元，並在 4 月 6 日的研究報告中給予該公司 “中性” 評級。Barclays 在 4 月 23 日的研究報告中將 Intuitive Surgical 的目標價設定為 651.00 美元，並給予該公司 “增持” 評級。Robert W. Baird 在 4 月 22 日的報告中將 Intuitive Surgical 的目標價從 575.00 美元上調至 610.00 美元，並給予該公司 “跑贏大盤” 評級。Jefferies Financial Group 在 4 月 22 日的報告中將 Intuitive Surgical 的目標價從 560.00 美元下調至 515.00 美元，並對該股票給予 “持有” 評級。最後，BTIG Research 在 4 月 22 日的報告中重申了 “買入” 評級，並將 Intuitive Surgical 的目標價設定為 574.00 美元。共有 18 位股票研究分析師對該股票給予了買入評級，7 位給予了持有評級，1 位給予了賣出評級。根據 MarketBeat 的數據，該股票目前的平均評級為 “適度買入”，共識目標價為 581.91 美元。</p>
</div><p><strong>Check Out Our Latest Stock Report on Intuitive Surgical</strong></p>
<div class="lb-trans"><p><strong>查看我們關於 Intuitive Surgical 的最新股票報告</strong></p>
</div><h2>Intuitive Surgical Trading Down 1.6%</h2>
<div class="lb-trans"><h2>Intuitive Surgical 股價下跌 1.6%</h2>
</div><ul>
<li>5 Stocks Racing Ahead as AI Supercharges Robotics</li>
</ul>
<div class="lb-trans"><ul>
<li>5 只股票在 AI 超級推動下快速上漲</li>
</ul>
</div><p>ISRG opened at $421.12 on Friday. The stock has a market cap of $149.14 billion, a price-to-earnings ratio of 51.04, a PEG ratio of 3.42 and a beta of 1.51. Intuitive Surgical has a 1 year low of $417.74 and a 1 year high of $603.88. The stock has a fifty day moving average price of $463.63 and a 200 day moving average price of $514.04.</p>
<div class="lb-trans"><p>ISRG 週五開盤價為 421.12 美元。該股票的市值為 1491.4 億美元，市盈率為 51.04，PEG 比率為 3.42，貝塔係數為 1.51。Intuitive Surgical 的一年低點為 417.74 美元，一年高點為 603.88 美元。該股票的 50 日移動平均價格為 463.63 美元，200 日移動平均價格為 514.04 美元。</p>
</div><p>Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings data on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.08 by $0.42. The firm had revenue of $2.77 billion during the quarter, compared to analysts' expectations of $2.62 billion. Intuitive Surgical had a return on equity of 15.98% and a net margin of 28.15%.The business's revenue for the quarter was up 23.0% on a year-over-year basis. During the same quarter last year, the firm earned $1.81 earnings per share. As a group, sell-side analysts forecast that Intuitive Surgical will post 8.57 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>直覺外科（NASDAQ:ISRG - 獲取免費報告）最近於 4 月 21 日發佈了季度財報。該醫療設備提供商報告每股收益（EPS）為 2.50 美元，超出分析師共識預期的 2.08 美元，超出幅度為 0.42 美元。該公司在本季度的收入為 27.7 億美元，而分析師預期為 26.2 億美元。Intuitive Surgical 的股本回報率為 15.98%，淨利潤率為 28.15%。該公司的季度收入同比增長 23.0%。去年同期，該公司每股收益為 1.81 美元。作為一個整體，賣方分析師預測 Intuitive Surgical 在當前財政年度將發佈 8.57 美元的每股收益。</p>
</div><h2>Insider Activity at Intuitive Surgical</h2>
<div class="lb-trans"><h2>Intuitive Surgical 的內部活動</h2>
</div><ul>
<li>Beyond Biotech—3 Healthcare Stocks for Growth-Minded Investors</li>
</ul>
<div class="lb-trans"><ul>
<li>超越生物技術——3 只適合成長型投資者的醫療股票</li>
</ul>
</div><p>In other Intuitive Surgical news, EVP Gary Loeb sold 400 shares of the firm's stock in a transaction dated Monday, May 11th. The stock was sold at an average price of $446.95, for a total transaction of $178,780.00. Following the transaction, the executive vice president directly owned 6,120 shares in the company, valued at $2,735,334. This trade represents a 6.13% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities &amp; Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Mark Brosius sold 2,362 shares of the firm's stock in a transaction dated Wednesday, March 4th. The shares were sold at an average price of $498.68, for a total value of $1,177,882.16. Following the transaction, the senior vice president owned 3,554 shares in the company, valued at approximately $1,772,308.72. This trade represents a 39.93% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders sold 5,647 shares of company stock valued at $2,760,359. Insiders own 0.60% of the company's stock.</p>
<div class="lb-trans"><p>在其他 Intuitive Surgical 的新聞中，執行副總裁 Gary Loeb 於 5 月 11 日星期一出售了 400 股該公司的股票。股票以平均價格 446.95 美元出售，總交易額為 178,780.00 美元。交易後，該執行副總裁直接持有該公司 6,120 股，價值 2,735,334 美元。此交易代表其持股比例減少了 6.13%。該交易已在證券交易委員會的備案中披露，相關信息可在 SEC 網站上查閲。該交易是在預先安排的 10b5-1 交易計劃下執行的。此外，資深副總裁 Mark Brosius 於 3 月 4 日星期三出售了 2,362 股該公司的股票。股票以平均價格 498.68 美元出售，總價值為 1,177,882.16 美元。交易後，資深副總裁持有該公司 3,554 股，價值約 1,772,308.72 美元。此交易代表其持股比例減少了 39.93%。有關此銷售的更多詳細信息可在官方 SEC 披露中找到。在過去一個季度中，內部人士出售了價值 2,760,359 美元的 5,647 股公司股票。內部人士持有該公司股票的 0.60%。</p>
</div><h2>Hedge Funds Weigh In On Intuitive Surgical</h2>
<div class="lb-trans"><h2>對 Intuitive Surgical 的對沖基金看法</h2>
</div><p>A number of institutional investors have recently made changes to their positions in the business. Gateway Wealth Partners LLC bought a new position in shares of Intuitive Surgical in the first quarter worth about $409,000. Blue Chip Partners LLC increased its stake in shares of Intuitive Surgical by 6.0% in the first quarter. Blue Chip Partners LLC now owns 2,274 shares of the medical equipment provider's stock worth $1,048,000 after purchasing an additional 129 shares during the period. Weiss Asset Management LP bought a new position in shares of Intuitive Surgical in the first quarter worth about $5,808,000. OMERS ADMINISTRATION Corp increased its stake in shares of Intuitive Surgical by 98.4% in the first quarter. OMERS ADMINISTRATION Corp now owns 289,024 shares of the medical equipment provider's stock worth $133,237,000 after purchasing an additional 143,345 shares during the period. Finally, Bradley Foster &amp; Sargent Inc. CT increased its stake in shares of Intuitive Surgical by 3.7% in the first quarter. Bradley Foster &amp; Sargent Inc. CT now owns 50,697 shares of the medical equipment provider's stock worth $23,371,000 after purchasing an additional 1,797 shares during the period. 83.64% of the stock is currently owned by institutional investors.</p>
<div class="lb-trans"><p>一些機構投資者最近對該公司的持倉進行了調整。Gateway Wealth Partners LLC 在第一季度購買了 Intuitive Surgical 的新股份，價值約 409,000 美元。Blue Chip Partners LLC 在第一季度將其在 Intuitive Surgical 的股份增加了 6.0%。Blue Chip Partners LLC 目前持有該醫療設備提供商的 2,274 股股票，價值 1,048,000 美元，此前在該期間內又購買了 129 股。Weiss Asset Management LP 在第一季度購買了 Intuitive Surgical 的新股份，價值約 5,808,000 美元。OMERS ADMINISTRATION Corp 在第一季度將其在 Intuitive Surgical 的股份增加了 98.4%。OMERS ADMINISTRATION Corp 目前持有該醫療設備提供商的 289,024 股股票，價值 133,237,000 美元，此前在該期間內又購買了 143,345 股。最後，Bradley Foster &amp; Sargent Inc. CT 在第一季度將其在 Intuitive Surgical 的股份增加了 3.7%。Bradley Foster &amp; Sargent Inc. CT 目前持有該醫療設備提供商的 50,697 股股票，價值 23,371,000 美元，此前在該期間內又購買了 1,797 股。83.64% 的股票目前由機構投資者持有。</p>
</div><h2>Key Stories Impacting Intuitive Surgical</h2>
<div class="lb-trans"><h2>影響 Intuitive Surgical 的關鍵故事</h2>
</div><p>Here are the key news stories impacting Intuitive Surgical this week:</p>
<div class="lb-trans"><p>以下是本週影響 Intuitive Surgical 的關鍵新聞故事：</p>
</div><ul>
<li>Positive Sentiment: Multiple recent articles highlighted Intuitive Surgical as a potential beneficiary of the AI boom in healthcare, arguing that every robotic procedure creates valuable data that can improve surgeon training, intraoperative guidance, and predictive analytics. Surgical Robotics Meets AI: Intuitive Surgical, Medtronic, and Stryker Are the Sleeper Plays of the Healthcare Boom</li>
<li>Positive Sentiment: Analysts at Erste Group Bank nudged up their FY2026 and FY2027 earnings estimates for ISRG, reinforcing expectations that earnings growth can continue above consensus. MarketBeat ISRG coverage</li>
<li>Positive Sentiment: Coverage around da Vinci 5 pointed to strong procedure growth and higher system utilization, suggesting the company’s newest platform is still gaining traction with surgeons and hospitals. Can ISRG's da Vinci 5 Momentum Sustain Procedure and Utilization Gains?</li>
<li>Neutral Sentiment: Several bullish opinion pieces said the recent selloff has made Intuitive Surgical look more attractive to growth investors, but these were mostly commentary rather than new company-specific catalysts. Intuitive Surgical Has Dropped 20% This Year. Wall Street Says It's Time to Buy.</li>
</ul>
<div class="lb-trans"><ul>
<li>積極情緒：多篇近期文章強調了直覺外科（Intuitive Surgical）作為醫療保健領域人工智能浪潮的潛在受益者，認為每一次機器人手術都會產生有價值的數據，從而改善外科醫生培訓、術中指導和預測分析。手術機器人與人工智能的結合：直覺外科、美敦力（Medtronic）和史崔克（Stryker）是醫療保健繁榮的潛在黑馬。</li>
<li>積極情緒：Erste Group Bank 的分析師上調了對 ISRG 的 2026 財年和 2027 財年的盈利預期，強化了盈利增長能夠持續超過市場共識的預期。MarketBeat 對 ISRG 的覆蓋。</li>
<li>積極情緒：關於達芬奇 5（da Vinci 5）的報道指出手術增長強勁，系統利用率提高，表明該公司的最新平台仍在外科醫生和醫院中獲得認可。ISRG 的達芬奇 5 能否維持手術和利用率的增長？</li>
<li>中性情緒：幾篇樂觀的評論文章表示，近期的拋售使得直覺外科對成長型投資者更具吸引力，但這些主要是評論而非新的公司特定催化劑。直覺外科今年已下跌 20%。華爾街表示，現在是買入的時機。</li>
</ul>
</div><h2>Intuitive Surgical Company Profile</h2>
<div class="lb-trans"><h2>直覺外科公司簡介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>(獲取免費報告)</p>
</div><p>Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon's hand movements into finer, scaled motions of small instruments inside the patient. Intuitive's business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.</p>
<div class="lb-trans"><p>直覺外科成立於 1995 年，總部位於加利福尼亞州陽光谷，是一家專注於設計、製造和服務機器人輔助手術系統的醫療技術公司。該公司以其達芬奇手術系統而聞名，該系統通過將外科醫生的手部動作轉化為患者體內小型儀器的更精細、縮放的運動，從而實現微創手術。直覺的業務集中在向醫院和手術中心提供系統、儀器及相關技術，旨在提高手術室的精確度、可視化和控制能力。</p>
</div><p>In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.</p>
<div class="lb-trans"><p>除了其核心手術平台外，直覺還銷售一系列可重複使用和一次性使用的儀器、配件和專有軟件，併為客户提供培訓、服務和臨牀支持。</p>
</div><h2>Further Reading</h2>
<div class="lb-trans"><h2>進一步閲讀</h2>
</div><ul>
<li>Five stocks we like better than Intuitive Surgical</li>
<li>Viking Sails to All-Time Highs—Fundamentals Signal More to Come</li>
<li>Datavalut Gains Traction: 5 Reasons to Sell Now</li>
<li>TMC Stock: Why This Pre-Revenue Miner Is Worth Watching</li>
<li>The Power Grid Is Dying—Is It Time to Buy Its Replacement?</li>
</ul>
<div class="lb-trans"><ul>
<li>我們更看好的五隻股票，勝過直覺外科</li>
<li>維京航運（Viking）創下歷史新高——基本面信號顯示未來還有更多</li>
<li>數據庫（Datavalut）獲得關注：現在賣出的五個理由</li>
<li>TMC 股票：為什麼這家尚未盈利的礦業公司值得關注</li>
<li>電網正在衰退——是時候購買其替代品了嗎？</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SVNSRw" alt="" original-src="https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx?Prefix=NASDAQ&amp;Symbol=ISRG"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。如對本故事有任何問題或意見，請發送郵件至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Intuitive Surgical Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在直覺外科嗎？</h2>
</div><p>Before you consider Intuitive Surgical, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮直覺外科之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其向客户推薦的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前買入……而直覺外科並不在名單上。</p>
</div><p>While Intuitive Surgical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然直覺外科目前在分析師中獲得了中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

直覺外科（NASDAQ 代碼：ISRG）被華爾街 Zen 升級為買入評級